CIFoundry
Back to Catalog
Cardiology
FDA 510(k) cleared May 21 2025 (K243866) after Breakthrough designation; Medicare NTAP from Oct 1 2026

InVision Precision Cardiac Amyloid

Save to shortlist
InVision Medical Technology2025

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

Precision Cardiac Amyloid is AI software that reviews routine echocardiogram videos of patients 65 and older and alerts the reading physician when the images suggest cardiac amyloidosis (AL or…

FDA:
510(k) K243866
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

Precision Cardiac Amyloid is AI software that reviews routine echocardiogram videos of patients 65 and older and alerts the reading physician when the images suggest cardiac amyloidosis (AL or ATTR), prompting confirmatory testing. It works with images from major ultrasound vendors and handheld devices.

EchocardiographyCardiac amyloidosisVendor-neutral

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is InVision Precision Cardiac Amyloid FDA cleared?
The public FDA database has one record that our team matched to InVision Precision Cardiac Amyloid. The most recent is 510(k) K243866 (InVision Precision Cardiac Amyloid), decided May 2025. Check that the cleared use matches how you plan to use it.FDA record K243866

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Cardiology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K243866 · 510(k) · May 2025
    InVision Precision Cardiac Amyloid

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (2)Show

Dated events on this listing's public record, newest first.

  1. Oct 31, 2026

    Added to CIFoundry

  2. May 21, 2025

    FDA 510(k) K243866 decision datesource

Developer

InVision Medical Technology

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.